0001062993-23-020118.txt : 20231103
0001062993-23-020118.hdr.sgml : 20231103
20231103183453
ACCESSION NUMBER: 0001062993-23-020118
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231101
FILED AS OF DATE: 20231103
DATE AS OF CHANGE: 20231103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelderman Kim
CENTRAL INDEX KEY: 0001739054
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 231377714
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-11-01
0000842023
BIO-TECHNE Corp
TECH
0001739054
Kelderman Kim
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
0
1
0
0
Chief Operating Officer
0
Common Stock
2023-11-01
4
A
0
14196
0
A
35421
D
Stock Option (Right to Buy)
37.70
2025-05-01
Common Stock
27392
27392
D
Stock Option (Right to Buy)
44.33
2025-08-08
Common Stock
84308
84308
D
Stock Option (Right to Buy)
47.60
2026-08-07
Common Stock
109536
109536
D
Stock Option (Right to Buy)
66.97
2027-08-05
Common Stock
69264
69264
D
Stock Option (Right to Buy)
66.97
2027-08-05
Common Stock
47952
47952
D
Restricted Stock Units
Common Stock
4980
4980
D
Stock Option (Right to Buy)
120.46
2028-08-06
Common Stock
19456
19456
D
Stock Option (Right to Buy)
120.46
2028-08-06
Common stock
25944
25944
D
Restricted Stock Units
Common Stock
6984
6984
D
Stock Options (Right to Buy)
94.52
2029-08-15
Common Stock
21704
21704
D
Stock Options (Right to Buy)
94.52
2029-08-15
Common Stock
28940
28940
D
Restricted Stock Units
Common Stock
8191
8191
D
Stock Options (Right to Buy)
84.61
2030-08-15
Common Stock
22043
22043
D
Stock Options (Right to Buy)
84.61
2030-08-15
Common Stock
29391
29391
D
Stock Options (Right to Buy)
52.83
2023-11-01
4
A
0
38252
0
A
2030-11-01
Common Stock
38252
38252
D
Represents 14,196 shares of restricted stock for which risks of forfeiture lapse as to 4,732 shares on each of 11/1/2024, 11/1/2025 and 11/1/2026.
Fully exercisable.
Options to purchase 35,964 shares are vested. Options to purchase 11,988 shares vest on 8/5/2024.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 12,972 shares are vested. Options to purchase 6,488 shares vest on 8/6/2024 and options to purchase 6,484 shares vest on 8/6/2025.
Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 7,236 shares are vested. Options to purchase 7,236 shares vest on each of 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
2023-11-03